GlassScriptPrepare for your visit
Reed A Dimmitt
Pediatric Gastroenterology · Birmingham, AL · NPI 1336180843
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,399.20
in general payments reported to CMS, 2019-2025 · $570 in 2025
The $570 reported for 2025 was more than what 76% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Who reported paying
General payments only, top 6 by amount.
- Genzyme Corporation $695.59
- Jazz Pharmaceuticals INC. $174.32
- Regeneron Healthcare Solutions, INC. $134.66
- Neuraxis, INC. $117.24
- Tolmar, INC. $89.63
- Alcresta Therapeutics, INC. $76.00
Drugs and devices associated with these payments
Dupixent Xywav Fensolvi Relizorb Crenessity Xolair Crysvita (Ak6) Vest Therapy Hillrom - Vest System Model 105 Home Care
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Reed Dimmitt listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/999061/reed-a-dimmitt